Evidence map›Paper›PMID 36036631›Full record

ArticlemBio2022

Adaptation of HIV-1/HIV-2 Chimeras with Defects in Genome Packaging and Viral Replication.

Jonathan M O Rawson, Olga A Nikolaitchik, Jennifer A Yoo, Xayathed Somoulay, Matthew A Brown, Franck S Mbuntcha Bogni, Vinay K Pathak, Ferri Soheilian, Ryan L Slack, Stefan G Sarafianos and 1 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Jonathan M O RawsonViral Recombination Section, HIV Dynamics and Replication Program, NCI, Frederick, Maryland, USA.
Olga A NikolaitchikViral Recombination Section, HIV Dynamics and Replication Program, NCI, Frederick, Maryland, USA.
Jennifer A YooViral Recombination Section, HIV Dynamics and Replication Program, NCI, Frederick, Maryland, USA.
Xayathed SomoulayViral Recombination Section, HIV Dynamics and Replication Program, NCI, Frederick, Maryland, USA.
Matthew A BrownViral Recombination Section, HIV Dynamics and Replication Program, NCI, Frederick, Maryland, USA.
Franck S Mbuntcha BogniViral Recombination Section, HIV Dynamics and Replication Program, NCI, Frederick, Maryland, USA.
Vinay K PathakViral Mutation Section, HIV Dynamics and Replication Program, NCI, Frederick, Maryland, USA.ORCID 0000-0003-2441-8412
Ferri SoheilianElectron Microscopy Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
Ryan L SlackLaboratory of Biochemical Pharmacology, Department of Pediatrics, Emory Universitygrid.189967.8 School of Medicine, Atlanta, Georgia, USA.
Stefan G SarafianosLaboratory of Biochemical Pharmacology, Department of Pediatrics, Emory Universitygrid.189967.8 School of Medicine, Atlanta, Georgia, USA.ORCID 0000-0002-5840-154X
Wei-Shau HuViral Recombination Section, HIV Dynamics and Replication Program, NCI, Frederick, Maryland, USA.ORCID 0000-0001-7733-623X
Emory University · USLeidos (United States) · US

Funding

Emory Training Program in Translational Research to End the HIV EpidemicT32AI157855 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2021 to 2026
$2.8M
Novel mechanism of integrase (IN) resistance to Dolutegravir through epistatic interactions between IN and the nucleocapsid and polypurine tract regions of HIV-1R01AI146017 · NIAID · EMORY UNIVERSITY · PI HACHIYA, ATSUKO, LYUMKIS, DMITRY · 2019 to 2023
$2.6M
NCI NIH HHS HHSN261201500003CNCI NIH HHS HHSN261201500003INIAID NIH HHS R01 AI146017NIAID NIH HHS T32 AI157855
6 · The paper itself

Abstract

Frequent recombination is a hallmark of retrovirus replication. In rare cases, recombination occurs between distantly related retroviruses, generating novel viruses that may significantly impact viral evolution and public health. These recombinants may initially have substantial replication defects due to impaired interactions between proteins and/or nucleic acids from the two parental viruses. However, given the high mutation rates of retroviruses, these recombinants may be able to evolve improved compatibility of these viral elements. To test this hypothesis, we examined the adaptation of chimeras between two distantly related human pathogens: HIV-1 and HIV-2. We constructed HIV-1-based chimeras containing the HIV-2 nucleocapsid (NC) domain of Gag or the two zinc fingers of HIV-2 NC, which are critical for specific recognition of viral RNA. These chimeras exhibited significant defects in RNA genome packaging and replication kinetics in T cells. However, in some experiments, the chimeric viruses replicated with faster kinetics when repassaged, indicating that viral adaptation had occurred. Sequence analysis revealed the acquisition of a single amino acid substitution, S18L, in the first zinc finger of HIV-2 NC. This substitution, which represents a switch from a conserved HIV-2 residue to a conserved HIV-1 residue at this position, partially rescued RNA packaging and replication kinetics. Further analysis revealed that the combination of two substitutions in HIV-2 NC, W10F and S18L, almost completely restored RNA packaging and replication kinetics. Our study demonstrates that chimeras of distantly related retroviruses can adapt and significantly enhance their replication by acquiring a single substitution.

Indexed as

HIV-1Amino Acid SequenceChimeraGenome, ViralHIV-2HumansRNA, ViralViral ProteinsVirus AssemblyVirus ReplicationRNA, ViralViral Proteinsadaptationchimeric virusevolutionGagHIV-1HIV-2lentivirusnucleocapsidrecombinationreplicationRNA packagingzinc finger

Identifiers

PMID36036631
PMCPMC9600866
OpenAlexW4293447241

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.